glycerophosphoinositol 4,5-bisphosphate has been researched along with Cardiac Conduction Defect in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abderemane-Ali, F; Amarouch, MY; Baró, I; Brasseur, R; Coyan, FC; Loussouarn, G; Marionneau, C; Mérot, J; Mordel, J; Nicolas, CS; Piron, J; Steenman, M; Thomas, A | 1 |
1 other study(ies) available for glycerophosphoinositol 4,5-bisphosphate and Cardiac Conduction Defect
Article | Year |
---|---|
A long QT mutation substitutes cholesterol for phosphatidylinositol-4,5-bisphosphate in KCNQ1 channel regulation.
Topics: Animals; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Cell Line; Chlorocebus aethiops; Cholesterol; COS Cells; Heart Conduction System; KCNQ1 Potassium Channel; Long QT Syndrome; Magnesium; Mutation; Phosphatidylinositol 4,5-Diphosphate | 2014 |